Company profile: Hendrix Genetics
1.1 - Company Overview
Company description
- Provider of animal genetic solutions and breeding programs for laying hens, turkeys, traditional poultry, swine, salmon, shrimp, and trout. Develops sustainable standards to improve animal performance, food safety, animal welfare, and environmental protection, addressing contemporary challenges in the animal protein sector. Headquartered in Boxmeer.
Products and services
- Breeding Programs: Hendrix Genetics architects performance-driven breeding programs improving animal performance and sustainability across multiple species, with focused activities in laying hens, turkeys, traditional poultry, pigs, salmon, and trout
- Animal Genetic Systems: Hendrix Genetics delivers multi-species genetic systems that enhance breeding for laying hens, turkeys, traditional poultry, swine, salmon, shrimp, and trout, tailored to contemporary animal protein sector challenges
- Sustainable Standards: Hendrix Genetics develops standards-based sustainable breeding frameworks ensuring food safety, animal welfare, and environmental protection across species, formalizing practices that support responsible animal protein production
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Hendrix Genetics
Bluebird Bio
HQ: United States
Website
- Description: Provider of gene therapies for severe genetic and rare diseases, developing gene addition treatments that modify patient cells to address underlying genetic causes using lentiviral vectors. Products include LentiGlobin for sickle cell disease, Lenti-D for cerebral adrenoleukodystrophy, and Zynteglo for beta-thalassemia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bluebird Bio company profile →
Boreal Genomics
HQ: Canada
Website
- Description: Provider of research tools and diagnostic tests based on monitoring tumor mutations from cell-free DNA in plasma.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Boreal Genomics company profile →
Epiontis
HQ: Germany
Website
- Description: Provider of immune cell identification and quantification services with accuracy and technical ease, using a novel molecular diagnostics technology, offering worldwide services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Epiontis company profile →
CosmosID
HQ: United States
Website
- Description: Provider of metagenomics and bioinformatics services for rapid identification of microorganisms in various samples, offering strain-level analysis via proprietary pipeline and database to detect bacteria, viruses, fungi, and more. Provides sequencing services (amplicon, shallow/deep shotgun, bacterial isolate) and CosmosID-HUB Microbiome, an online platform with pipelines for amplicon and shotgun data, plus targeted tests and whole genome analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CosmosID company profile →
Tome Biosciences
HQ: United States
Website
- Description: Provider of programmable gene insertion technologies, including Integrase-Mediated PGI using a proprietary integrase to integrate large DNA sequences (>1,000 bp) at user-defined genomic locations and Ligase-Mediated PGI using a DNA ligase for small sequence insertion, plus integrative gene therapies for PKU (PAH), ASCVD (ApoA-1), HCU (CBS), and hereditary hemochromatosis (HFE).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tome Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Hendrix Genetics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Hendrix Genetics
2.2 - Growth funds investing in similar companies to Hendrix Genetics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Hendrix Genetics
4.2 - Public trading comparable groups for Hendrix Genetics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →